CN1745818A - Pill for treating coronary heart disease - Google Patents
Pill for treating coronary heart disease Download PDFInfo
- Publication number
- CN1745818A CN1745818A CN 200510086623 CN200510086623A CN1745818A CN 1745818 A CN1745818 A CN 1745818A CN 200510086623 CN200510086623 CN 200510086623 CN 200510086623 A CN200510086623 A CN 200510086623A CN 1745818 A CN1745818 A CN 1745818A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- heart disease
- coronary heart
- pill
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese patent medicine in the form of pill for treating coronary heart disease, angina pectoris is prepared from 19 Chinese-medicinal materials including fleece flower root, ginseng, musk, red sage root, etc. It has high curative effect.
Description
Technical field
The present invention relates to a kind of pill for the treatment of coronary heart disease, is that heart diseases such as a kind of main treatment coronary heart disease, angina pectoris are the Chinese patent medicine of raw material with the Chinese herbal medicine.
Background technology
Coronary heart disease and the angina pectoris that causes thus, heart are intermittently, symptoms such as arrhythmia and myocardial infarction are a kind of commonly encountered diseases, and the patient can not be engaged in physical work, and serious can't take care of oneself, even dead.Current, treatment coronary heart disease Western medicine commonly used, these Western medicine not only cost an arm and a leg, and toxic and side effects is also higher, and it is the work of always studying that coronary heart disease is treated in utilization Chinese herbal treatment or auxiliary smelting, but present medicine can only alleviate the patient suffering, can not effect a radical cure, and curative effect can not be satisfactory.
Summary of the invention
The purpose of this invention is to provide a kind of pill for the treatment of coronary heart disease, can treat and effect a radical cure coronary heart disease, and other heart disease is also had better curative effect.
Solution of the present invention is according to the rule of the traditional Chinese medical science to coronary heart disease treatment, i.e. the body resistance strengthening and constitution consolidating, the kidney invigorating collateral dredging, blood circulation promoting and blood stasis dispelling, detoxifcation pain relieving, hard masses softening and resolving and antiinflammatory curing rheumatism, the blood sugar lowering blood fat, the present invention forms according to above-mentioned rule, can the kidney invigorating collateral dredging, blood circulation promoting and blood stasis dispelling, the detoxifcation pain relieving, the antiinflammatory curing rheumatism again can the body resistance strengthening and constitution consolidating, the blood sugar lowering blood fat, hard masses softening and resolving.Radix Adenophorae of the present invention, Radix Salviae Miltiorrhizae, Radix Polygoni Multiflori enriching yin and nourishing kidney, tonifying blood and regulating menstruation; Moschus, Rhizoma Chuanxiong, Radix Angelicae Pubescentis, Rhizoma Cimicifugae, Sanguis Draxonis and daybreak lean intelligence are calmed the nerves, a surname's air to open key, and the strongly fragrant eliminating phlegm that looses, wind-damp dispelling, dampness is stimulated the menstrual flow, and removing blood stasis with potent drugs is by blood, and the detoxifcation parasite killing grinds the long-pending painful abdominal mass that disappears, the detumescence convergence; Semen Cuscutae and the Herba Dendrobii antidiarrheal of astringing the lung, lung benefiting spleen invigorating, the arresting sweating that promotes the production of body fluid, reinforcing the kindey to control nocturnal emission; Herba Saussureae Involueratae, Ganoderma lucidum seu Japonicum clearing heat and relieving fidgetness are promoted the production of body fluid and are quenched one's thirst, nourishing the lung to arrest cough; Radix Ginseng and Radix Morindae Officinalis invigorating QI to relieve exhaustion, promoting the production of body fluid and inducing sedation of the mind, reuniting the fractured tendons and bones, blood circulation regulating, strong waist knee joint; Cinnabaris and succinum mind tranquilizing and the heart calming, tranquilizing by nourishing the heart, arresting sweating promotes the production of body fluid, and moisturizes; Medulla Junci and Semen Cassiae eliminating dampness and diuresis, liver heat removing and eyesight improving, tranquilizing mind, strengthening the spleen stomach; The present invention has eliminating evil just the wound, sets upright and does not stay heresy, the kidney invigorating collateral dredging, warm network blood-activating analgetic, intelligence promoting and the mind tranquilizing, a surname's air to open key, the strongly fragrant eliminating phlegm that looses, wind-damp dispelling, dampness is stimulated the menstrual flow, removing blood stasis with potent drugs is by blood, and the detoxifcation parasite killing is subsided a swelling and restrained, and the blood sugar lowering blood fat has the sick effect of good radical cure.
The present invention is made by the following weight proportion raw material:
22～33 parts of 24～36 portions of Medulla Juncies of 20～30 parts of Radix Adenophoraes of Radix Morindae Officinalis
18～27 parts of 20～30 parts of Radix Polygoni Multiflori of 24～36 parts of Semen Cuscutae of Radix Carpesii
18～27 parts of 20～30 parts of Rhizoma Chuanxiongs of 24～36 parts of Herba Saussureae Involuerataes of Radix Ginseng
1～4 part in 16～24 parts of Cinnabaris of 22～33 parts of Sanguis Draxonis of Herba Dendrobii
22～33 parts of 14～21 parts of Rhizoma Cimicifugaes of 18～27 parts of succinums of Radix Angelicae Pubescentis
16～24 parts of 14～21 parts of Semen Cassiaes of 1～4 portion of Ganoderma lucidum seu Japonicum of Moschus
16～24 parts of Radix Salviae Miltiorrhizaes.
The weight proportion of each raw material of formula optimization of the present invention is:
25～30 parts of 27～33 portions of Medulla Juncies of 23～27 parts of Radix Adenophoraes of Radix Morindae Officinalis
21～24 parts of 23～27 parts of Radix Polygoni Multiflori of 27～33 parts of Semen Cuscutae of Radix Carpesii
21～24 parts of 23～27 parts of Rhizoma Chuanxiongs of 27～33 parts of Herba Saussureae Involuerataes of Radix Ginseng
1～3 part in 19～21 parts of Cinnabaris of 25～30 parts of Sanguis Draxonis of Herba Dendrobii
25～30 parts of 16～18 parts of Rhizoma Cimicifugaes of 21～24 parts of succinums of Radix Angelicae Pubescentis
19～21 parts of 16～18 parts of Semen Cassiaes of 1～3 portion of Ganoderma lucidum seu Japonicum of Moschus
19～21 parts of Radix Salviae Miltiorrhizaes.
The weight proportion of best each raw material of prescription of the present invention is:
27 parts of 30 portions of Medulla Juncies of 25 parts of Radix Adenophoraes of Radix Morindae Officinalis
22 parts of 25 parts of Radix Polygoni Multiflori of 30 parts of Semen Cuscutae of Radix Carpesii
22 parts of 25 parts of Rhizoma Chuanxiongs of 30 parts of Herba Saussureae Involuerataes of Radix Ginseng
2 parts in 20 parts of Cinnabaris of 27 parts of Sanguis Draxonis of Herba Dendrobii
27 parts of 17 parts of Rhizoma Cimicifugaes of 22 parts of succinums of Radix Angelicae Pubescentis
20 parts of 17 parts of Semen Cassiaes of 2 portions of Ganoderma lucidum seu Japonicumes of Moschus
20 parts of Radix Salviae Miltiorrhizaes.
Described medicament is a said pill on any pharmaceutics.
The present invention can be made into pill, and method for making is that mix homogeneously is made medicated powder with said herbal medicine drying and crushing to 120～200 order fine powders, more per 100 gram medicated powder is added 90 gram refined honeys, and the patent medicine of making every ball 7 grammes per square metres gets final product.Usually oral, one time one ball, a twice-daily.The present invention is called " heart is multiple red ".
Clinical drug of the present invention uses the result to show that following advantage is arranged;
1, the Chinese herbal medicine each component selected for use of the present invention meets the pharmaceutical control law regulation, utilizes the comprehensive function treatment coronary heart disease of the Chinese medicine of respectively distinguishing the flavor of, and does not have chemical sweeting agent, and is nontoxic to human body.Show that through animal acute toxicity test underproof animal end sees any toxic reaction, its main organs does not have tangible change yet, and mice is 40g crude drug/kg to the maximum tolerated dose of medicine of the present invention, is 156 times of clinical people's consumption, and safety of medicine is reliable.
2, the present invention need not decoct, no bitterness sense, and rich in proteins in the medicine, glucose, phlegmatic temperament, organic acid, fatty oil, vitamin and nearly tens seed amino acids also contain various trace elements such as ginsenoside and ferrum, are beneficial to absorption of human body, health invigorating, and taking convenience.
3, the present invention can treat and effect a radical cure coronary heart disease effectively, and other heart disease is also had better curative effect, has improved patient's life quality and the time greatly, and higher healing rehabilitation efficacy is arranged.
For showing the therapeutic effect of medicine of the present invention, as follows through clinical test results to coronary heart disease; Treat various patients with coronary heart disease 67 examples, radical cure rehabilitation 40 examples, produce effects 17 examples, effective 3 examples, invalid 7 examples, effective percentage reaches more than 89%.Treat other heart disease 40 examples, radical cure rehabilitation 24 examples, produce effects 8 examples, effective 3 examples, invalid 5 examples, effective percentage reaches more than 87%.
The specific embodiment
Take by weighing raw material by following proportioning: Radix Morindae Officinalis 25g, Radix Adenophorae 30g, Medulla Junci 27g, Radix Carpesii 30g, Semen Cuscutae 25g, Radix Polygoni Multiflori 22g, Radix Ginseng 30g, Herba Saussureae Involueratae 25g, Rhizoma Chuanxiong 22g, Herba Dendrobii 27g, Sanguis Draxonis 20g, Cinnabaris 2g, Radix Angelicae Pubescentis 22g, succinum 17g, Rhizoma Cimicifugae 27g, Moschus 2g, Ganoderma lucidum seu Japonicum 17g, Semen Cassiae 20g, Radix Salviae Miltiorrhizae 20g.
Production method is as follows:
Method for making is that mix homogeneously is made medicated powder with said herbal medicine drying and crushing to 120～200 order fine powders, adds 90 gram refined honeys by per 100 gram medicated powder again, and the patent medicine of making every ball 7 grammes per square metres gets final product.Usually oral, one time one ball, a twice-daily.
Claims (3)
1, a kind of pill for the treatment of coronary heart disease is characterized in that it is made by the following weight proportion raw material:
22～33 parts of 24～36 portions of Medulla Juncies of 20～30 parts of Radix Adenophoraes of Radix Morindae Officinalis
18～27 parts of 20～30 parts of Radix Polygoni Multiflori of 24～36 parts of Semen Cuscutae of Radix Carpesii
18～27 parts of 20～30 parts of Rhizoma Chuanxiongs of 24～36 parts of Herba Saussureae Involuerataes of Radix Ginseng
1～4 part in 16～24 parts of Cinnabaris of 22～33 parts of Sanguis Draxonis of Herba Dendrobii
22～33 parts of 14～21 parts of Rhizoma Cimicifugaes of 18～27 parts of succinums of Radix Angelicae Pubescentis
16～24 parts of 14～21 parts of Semen Cassiaes of 1～4 portion of Ganoderma lucidum seu Japonicum of Moschus
16～24 parts of Radix Salviae Miltiorrhizaes.
2, a kind of pill for the treatment of coronary heart disease according to claim 1, wherein the weight proportion of each raw material is:
25～30 parts of 27～33 portions of Medulla Juncies of 23～27 parts of Radix Adenophoraes of Radix Morindae Officinalis
21～24 parts of 23～27 parts of Radix Polygoni Multiflori of 27～33 parts of Semen Cuscutae of Radix Carpesii
21～24 parts of 23～27 parts of Rhizoma Chuanxiongs of 27～33 parts of Herba Saussureae Involuerataes of Radix Ginseng
1～3 part in 19～21 parts of Cinnabaris of 25～30 parts of Sanguis Draxonis of Herba Dendrobii
25～30 parts of 16～18 parts of Rhizoma Cimicifugaes of 21～24 parts of succinums of Radix Angelicae Pubescentis
19～21 parts of 16～18 parts of Semen Cassiaes of 1～3 portion of Ganoderma lucidum seu Japonicum of Moschus
19～21 parts of Radix Salviae Miltiorrhizaes.
3, a kind of pill for the treatment of coronary heart disease according to claim 1, wherein the weight proportion of each raw material is:
27 parts of 30 portions of Medulla Juncies of 25 parts of Radix Adenophoraes of Radix Morindae Officinalis
22 parts of 25 parts of Radix Polygoni Multiflori of 30 parts of Semen Cuscutae of Radix Carpesii
22 parts of 25 parts of Rhizoma Chuanxiongs of 30 parts of Herba Saussureae Involuerataes of Radix Ginseng
2 parts in 20 parts of Cinnabaris of 27 parts of Sanguis Draxonis of Herba Dendrobii
27 parts of 17 parts of Rhizoma Cimicifugaes of 22 parts of succinums of Radix Angelicae Pubescentis
20 parts of 17 parts of Semen Cassiaes of 2 portions of Ganoderma lucidum seu Japonicumes of Moschus
20 parts of Radix Salviae Miltiorrhizaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100866236A CN1305508C (en) | 2005-10-17 | 2005-10-17 | Pill for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100866236A CN1305508C (en) | 2005-10-17 | 2005-10-17 | Pill for treating coronary heart disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1745818A true CN1745818A (en) | 2006-03-15 |
| CN1305508C CN1305508C (en) | 2007-03-21 |
Family
ID=36165636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100866236A Expired - Fee Related CN1305508C (en) | 2005-10-17 | 2005-10-17 | Pill for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1305508C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103751474A (en) * | 2013-12-31 | 2014-04-30 | 齐洪涛 | Chinese herbal medicine formula for treating three-degree atrioventricular block and preparation method thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1085083C (en) * | 1993-02-17 | 2002-05-22 | 山海丹企业集团西安中医多学科研究所 | Prescription and production method of medicine to cure stenocardia-type coronary heart disease |
| CN1127126A (en) * | 1995-01-16 | 1996-07-24 | 张吉祥 | Traditional Chinese medicine for coronary heart disease and preparing method |
| CN1290545C (en) * | 2003-01-09 | 2006-12-20 | 河南省联谊制药有限公司 | Medicine for curing coronary heart disease |
-
2005
- 2005-10-17 CN CNB2005100866236A patent/CN1305508C/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103751474A (en) * | 2013-12-31 | 2014-04-30 | 齐洪涛 | Chinese herbal medicine formula for treating three-degree atrioventricular block and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1305508C (en) | 2007-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102058673B (en) | Chinese medicine composition for expelling wind and removing dampness and preparation method thereof | |
| CN1861187A (en) | Medicated wine for treating rheumatosis and osteoarthropathy | |
| CN101125166A (en) | External-applied traditional Chinese medicine for treating rheumatism | |
| CN103520505A (en) | Traditional Chinese medicine preparation for treating neurasthenia and preparation method thereof | |
| CN1232266C (en) | Chinese medicinal capsules for apoplexy and thoracic palsy and preparation thereof | |
| CN100544761C (en) | A kind of medicine for the treatment of coronary heart disease | |
| CN103495042A (en) | Traditional Chinese medicine composition for treating migraine | |
| CN1840160A (en) | Powder for resisting hyperosteogeny | |
| CN1305508C (en) | Pill for treating coronary heart disease | |
| CN1063338C (en) | Traditional Chinese medicine preparation for curing cervical and lumbar hyperosteogeny | |
| CN103585414B (en) | Pharmaceutical composition for treating sciatica and osteoporosis | |
| CN1177605C (en) | Pill for treating rheumatic carditis | |
| CN100346807C (en) | Fuming-washing Chinese medicine for treating bone joint disease | |
| CN1090503C (en) | Medical capsule for treating rheumatism and building up body and its preparing process | |
| CN100398143C (en) | Medicament for treating vitiligo | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN103893606B (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
| CN1209130C (en) | Medical preparation of treating necrosis of femoral head | |
| CN1927349A (en) | Traditional Chinese medicine for treating rheumatism and its preparing process | |
| CN101125180A (en) | Traditional Chinese medicine for curing rheumatism | |
| CN105560427A (en) | Transdermal gate-freeing powder | |
| CN105560537A (en) | Medicine composition for treating osteoartritis and preparation method thereof | |
| CN105194411A (en) | Formula of traditional Chinese medicine for treating scapulobumeral periarthritis | |
| CN1172709C (en) | Medicine for treating rheumatalgia | |
| CN1559502A (en) | Chinese medicinal composition for treating sexual dysfunction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070321 Termination date: 20091117 |